Article Details
Retrieved on: 2024-11-21 21:47:37
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
... Investments and Correlation Ventures. This investment will advance Valora's proprietary AbLec platform to develop novel immunotherapeutics.
Article found on: pulse2.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here